Blood thinner plus immune therapy for Behçet's disease blood clots
Part of Eyes & vision, Genetic & congenital, Heart & circulation, Mouth & dental, Skin clinical trials.
This study tests whether adding a blood thinner (rivaroxaban) to standard immune therapy is better than immune therapy alone for treating blood clots in the legs caused by Behçet's disease. It may help prevent clots from getting worse or recurring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old
- You have Behçet's disease
- You have a new blood clot in your leg (diagnosed within the last 14 days)
- You have not had prior blood clots or taken immune-suppressing drugs for them
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use effective birth control
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the health records and blood tests of children and young adults with Behçet disease to learn more about the condition. It also compares their results with healthy children to find clues that may help doctors better understand and treat Behçet disease.
This trial tests whether adding a blood thinner (anticoagulant) to steroid therapy is more effective than steroids alone for treating deep vein thrombosis (a blood clot in a large vein) in people with Behçet's syndrome. It aims to find the best way to prevent future clots and reduce side effects.
This Phase 2 trial tests tocilizumab and tofacitinib to see if they can better control vascular (blood-vessel) Behçet’s syndrome. It may help by lowering inflammation and reducing complications from aneurysms in the aorta or peripheral arteries.
This study looks at how the thickness of the femoral vein wall and certain markers of inflammation relate to Behcet disease. It may help doctors better understand and monitor the condition.
This trial tests a new medicine, HSK44459, to see if it can reduce mouth ulcers in people with Behçet's disease. If you have frequent mouth sores from Behçet's, this treatment might help.
This study tests a new pill called Hemay005 for adults with Behçet's disease who have at least two mouth sores that need treatment beyond creams or rinses. It aims to see if the drug safely reduces mouth ulcers.
Hear when a new Behcet Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.